(Q30308218)

16 June 2017

title

Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay (English)

1 reference

16 June 2017

2

Robert G Webster

1 reference

16 June 2017

3

Frederick G Hayden

1 reference

16 June 2017

1

Larisa V Gubareva

1 reference

16 June 2017

publication date

1 January 2002

1 reference

16 June 2017

1 reference

16 June 2017

volume

53

1 reference

16 June 2017

issue

1

1 reference

16 June 2017

page(s)

47-61

1 reference

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Calcium is needed for the thermostability of influenza B virus neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Influenza virus sialidase: effect of calcium on steady-state kinetic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Influenza virus neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Assays for antiviral drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Resistance of influenza viruses to neuraminidase inhibitors--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Substrate, inhibitor, or antibody stabilizes the Glu 119 Gly mutant influenza virus neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Oral oseltamivir treatment of influenza in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

Position statement: global neuraminidase inhibitor susceptibility network

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900192-9

7 January 2021

10.1016/S0166-3542(01)00192-9

Identifiers

DOI

1 reference

release_axq47reyrnfu3gb2bg7z2q3h4u

16 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/axq47reyrnfu3gb2bg7z2q3h4u

24 November 2022

mapped directly with Wikidata item

1 reference